Peptide Therapeutics Research
75 peptides · 48 approved · 27 targets
Total Peptides
75
Approved
48
In Pipeline
27
Targets
27
Avg MW (Da)
2,190
Explore
Peptide Dictionary
75 entries
Educational knowledge base covering benefits, mechanisms, administration, and use cases.
Semaglutide — GLP-1 Agonist
Tirzepatide — GLP-1 Agonist
Octreotide — Somatostatin Analog
Peptide Targets
27 entries
Biological targets and receptors relevant to peptide drug development.
GLP-1R — 13 peptides
GnRH-R — 6 peptides
GIP-R — 4 peptides
By Classification
Therapeutic54 (72%)
Research21 (28%)
Top Peptide Classes
Neuropeptide22
GLP-1 Agonist12
GnRH Analog6
Melanocortin Agonist4
Growth Hormone Releasing Peptide4
Somatostatin Analog3
Growth Hormone Secretagogue3
Proteasome Inhibitor2
Featured Peptides
| Peptide | Class | Phase | Target | Route | MW |
|---|---|---|---|---|---|
| BPC-157(Body Protection Compound-157) | Neuropeptide | Research | — | SC Injection;Oral | 1,419 Da |
| TB-500(Thymosin Beta-4 Fragment) | Neuropeptide | Research | — | SC Injection | 4,963 Da |
| Thymosin Beta-4(Tβ4) | Neuropeptide | Research | — | SC Injection | 4,963 Da |
| CJC-1295(CJC-1295 DAC) | Growth Hormone Secretagogue | Research | GHRH-R | SC Injection | 3,367 Da |
| Ipamorelin(NNC 26-0161) | Growth Hormone Releasing Peptide | Research | GHS-R | SC Injection | 711 Da |
| AOD-9604(Anti-Obesity Drug 9604) | Neuropeptide | Research | — | SC Injection | 1,815 Da |
| GHK-Cu(Copper Peptide GHK) | Neuropeptide | Research | — | Topical;SC Injection | 403 Da |
| DSIP(Delta Sleep-Inducing Peptide) | Neuropeptide | Research | — | SC Injection;IV Infusion | 848 Da |
| Melanotan II(MT-II) | Melanocortin Agonist | Research | MC4R | SC Injection | 1,024 Da |
| MOTS-c(Mitochondrial ORF of Twelve S rRNA Type-c) | Neuropeptide | Research | — | SC Injection | 2,174 Da |